CIK 0000894158 · Non-accelerated filer<br>Smaller reporting company
Theriva Biologics, Inc.
Sign in to watch- Ticker
- TOVX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 133808303
- Phone
- (734) 332-7800
- Business address
- 9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
- Former names
- Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-02 | KIRK RANDAL J 10% owner | Sale | −3,737 | $0.66 | $2K | 88,422 |
| 2019-04-02 | KIRK RANDAL J 10% owner | Sale | −9,909 | $0.66 | $7K | 234,493 |
| 2019-04-01 | KIRK RANDAL J 10% owner | Sale | −11,413 | $0.67 | $8K | 92,159 |
| 2019-04-01 | KIRK RANDAL J 10% owner | Sale | −30,265 | $0.67 | $20K | 244,402 |
| 2018-12-06 | Kraws Jeffrey J Director | Grant or award · Stock Options | +79,500 | 79,500 | ||
| 2018-12-06 | SHALLCROSS STEVEN A CEO and CFO | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2018-12-06 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +79,500 | 79,500 | ||
| 2018-12-06 | Tarriff Scott Director | Grant or award · Stock Options | +79,500 | 79,500 | ||
| 2017-12-20 | SHALLCROSS STEVEN A Interim CEO and CFO | Grant or award · Stock Options | +550,000 | 550,000 | ||
| 2017-12-20 | Sliman Joseph A. Chief Medical Officer | Grant or award · Stock Options | +410,000 | 410,000 | ||
| 2017-12-20 | Kraws Jeffrey J Director | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2017-12-20 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2017-12-20 | Tarriff Scott Director | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2017-03-14 | Kraws Jeffrey J Director | Option exercise | +228,773 | $0.09 | $21K | 228,773 |
| 2017-03-14 | Kraws Jeffrey J Director | Option exercise · Stock Options (right to buy) | −228,773 | 0 | ||
| 2017-01-17 | Sliman Joseph A. Chief Medical Officer | Grant or award · Stock Options | +188,927 | 188,927 | ||
| 2016-11-30 | Tarriff Scott Director | Grant or award · Stock Options | +168,750 | 168,750 | ||
| 2016-11-30 | Riley Jeffrey Scott Chief Executive Officer | Grant or award · Stock Options | +1,129,000 | 1,129,000 | ||
| 2016-11-30 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +168,750 | 168,750 | ||
| 2016-11-30 | Kraws Jeffrey J Director | Grant or award · Stock Options | +168,750 | 168,750 |
Page 3 of 6 · 113 trades